A thermolabile aldolase A mutant causes fever-induced recurrent rhabdomyolysis without hemolytic anemia

PLoS Genet. 2014 Nov 13;10(11):e1004711. doi: 10.1371/journal.pgen.1004711. eCollection 2014 Nov.

Abstract

Aldolase A deficiency has been reported as a rare cause of hemolytic anemia occasionally associated with myopathy. We identified a deleterious homozygous mutation in the ALDOA gene in 3 siblings with episodic rhabdomyolysis without hemolytic anemia. Myoglobinuria was always triggered by febrile illnesses. We show that the underlying mechanism involves an exacerbation of aldolase A deficiency at high temperatures that affected myoblasts but not erythrocytes. The aldolase A deficiency was rescued by arginine supplementation in vitro but not by glycerol, betaine or benzylhydantoin, three other known chaperones, suggesting that arginine-mediated rescue operated by a mechanism other than protein chaperoning. Lipid droplets accumulated in patient myoblasts relative to control and this was increased by cytokines, and reduced by dexamethasone. Our results expand the clinical spectrum of aldolase A deficiency to isolated temperature-dependent rhabdomyolysis, and suggest that thermolability may be tissue specific. We also propose a treatment for this severe disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Hemolytic / genetics
  • Anemia, Hemolytic / pathology
  • Arginine / metabolism
  • Dexamethasone / administration & dosage
  • Erythrocytes / pathology
  • Female
  • Fever / etiology
  • Fever / genetics*
  • Fever / pathology
  • Fructose-Bisphosphate Aldolase / chemistry
  • Fructose-Bisphosphate Aldolase / genetics*
  • Glycogen Storage Disease / genetics*
  • Glycogen Storage Disease / pathology
  • Glycolysis
  • Humans
  • Male
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / pathology
  • Myoblasts / metabolism
  • Myoblasts / pathology
  • Pedigree
  • Protein Conformation
  • Rhabdomyolysis / etiology
  • Rhabdomyolysis / genetics*
  • Rhabdomyolysis / pathology

Substances

  • Dexamethasone
  • Arginine
  • Fructose-Bisphosphate Aldolase

Supplementary concepts

  • Glycogen Storage Disease XII

Grants and funding

This study was supported by grants from the Association Française contre les Myopathies (grant no. 15947), the Agence Nationale de la Recherche (ANR-13-BSV1-0020-01) and the Fondation Lejeune to PdL. AM was supported by the Fondation Bettencourt, the Association Connaître les Syndromes Cérébelleux, L'association Noa-Luu, L'association Nos Anges et l'association Hyperinsulinisme. The Prix Robert-Debré was awarded to PdL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.